Australia markets closed

Unity Biotechnology, Inc. (UBX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.20+0.22 (+3.15%)
At close: 4:00PM EST

7.20 0.00 (0.00%)
Pre-market: 5:01AM EST

Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
Total revenue
0
0
0
1,382
Operating expenses
Research development
70,957
70,957
58,907
37,373
Selling general and administrative
20,046
20,046
16,016
9,617
Total operating expenses
89,651
91,003
74,923
46,990
Operating income or loss
-89,651
-91,003
-74,923
-45,608
Total other income/expenses net
4,185
5,537
-4,787
-103
Income before tax
-82,177
-82,177
-76,398
-44,656
Income from continuing operations
-82,177
-82,177
-76,398
-44,656
Net income
-82,177
-82,177
-76,398
-44,656
Net income available to common shareholders
-82,177
-82,177
-76,398
-44,656
Basic EPS
-
-1.88
-2.70
-1.49
Diluted EPS
-
-1.88
-2.70
-1.49
Basic average shares
-
43,625
28,270
30,039
Diluted average shares
-
43,625
28,270
30,039
EBITDA
-
-88,340
-72,743
-44,304